Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.
McMillan
R
R
D003078:Colchicine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005500:Follow-Up Studies; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction
D003520:Cyclophosphamide; D003613:Danazol; D003078:Colchicine; D011241:Prednisone